Profiel
Karl Y.
Johe was the founder of Seneca Biopharma, Inc. which was founded in 1996, where he held the titles of Chairman & Chief Scientific Officer until 2016.
In 1993, he worked as a Staff Scientist-Molecular Biology Laboratory at the National Institute of Neurological Disorders & Stroke until 1997.
Dr. Johe's education history includes an undergraduate and graduate degree from the University of Kansas and a doctorate from Albert Einstein College of Medicine, Inc.
Eerdere bekende functies van Karl Johe
| Bedrijven | Functie | Einde |
|---|---|---|
| National Institute of Neurological Disorders & Stroke | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 |
| PALISADE BIO, INC. | Oprichter | - |
Opleiding van Karl Johe
| University of Kansas | Graduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| National Institute of Neurological Disorders & Stroke | Government |